Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1

Tung Yueh Chuang, Jie Min, Hsiao Li Wu, Cristina McCrary, Lawrence C. Layman, Michael P. Diamond, Ricardo Azziz, Ayman Al-Hendy, Yen Hao Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We previously demonstrated that berberine (BBR) inhibits cell proliferation and induces apoptosis in a human uterine leiomyoma (UtLM) cell line but does not demonstrate a significant cytotoxic effect in a normal human uterine smooth muscle (UtSM) cell line. However, the mechanisms of this inhibition are unclear. Of note, cyclooxygenase 2 (COX2) and pituitary tumor-transforming gene 1 (PTTG1) are overexpressed in human uterine leiomyomata and are involved in the pathogenesis of uterine fibroids (UFs). We found that COX2 and PTTG1 were overexpressed in UtLM and that BBR decreased COX2 and PTTG1 expression in UtLM cells. Our data support that UtLM and UtSM are immortalized cell lines without phenotypic alterations from parental cell types and suggest that COX2 and PTTG1 are molecular targets for BBR. However, studies in these cell lines may not reveal all activities of BBR in vivo, and we therefore proceeded to test in this report the antitumor effects of BBR in an UF nude mouse xenograft model. When UF nude mice were killed at 7 weeks, tumor weight in controls was 45 ± 7 mg versus 20 ± 3 mg (P < .05) in the low-dose (5 mg/kg) and 7 ± 3 mg (P < .01) in the high-dose (10 mg/kg) BBR groups, respectively. Expression of proliferation markers, cell cycle-related genes, and UF-related genes was downregulated in tumors. No unusual behavioral changes and no signs of kidney or liver damage were observed in the animals with BBR treatment. In conclusion, our data suggests that (a) COX2 and PTTG1 are molecular targets for BBR and (b) BBR is potentially an effective and safe anti-UF agent.

Original languageEnglish (US)
Pages (from-to)1005-1013
Number of pages9
JournalReproductive Sciences
Volume24
Issue number7
DOIs
StatePublished - Oct 30 2016

Fingerprint

Berberine
Leiomyoma
Pituitary Neoplasms
Cyclooxygenase 2
Oncogenes
Down-Regulation
Cell Proliferation
Cell Line
Myometrium
Nude Mice
Smooth Muscle Myocytes
cdc Genes
Tumor Burden
Heterografts
Apoptosis

Keywords

  • berberine
  • COX2
  • leiomyoma
  • PTTG1
  • uterine fibroids

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1. / Chuang, Tung Yueh; Min, Jie; Wu, Hsiao Li; McCrary, Cristina; Layman, Lawrence C.; Diamond, Michael P.; Azziz, Ricardo; Al-Hendy, Ayman; Chen, Yen Hao.

In: Reproductive Sciences, Vol. 24, No. 7, 30.10.2016, p. 1005-1013.

Research output: Contribution to journalArticle

Chuang, Tung Yueh ; Min, Jie ; Wu, Hsiao Li ; McCrary, Cristina ; Layman, Lawrence C. ; Diamond, Michael P. ; Azziz, Ricardo ; Al-Hendy, Ayman ; Chen, Yen Hao. / Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1. In: Reproductive Sciences. 2016 ; Vol. 24, No. 7. pp. 1005-1013.
@article{26207765ec2041c48935f30c999cfddf,
title = "Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1",
abstract = "We previously demonstrated that berberine (BBR) inhibits cell proliferation and induces apoptosis in a human uterine leiomyoma (UtLM) cell line but does not demonstrate a significant cytotoxic effect in a normal human uterine smooth muscle (UtSM) cell line. However, the mechanisms of this inhibition are unclear. Of note, cyclooxygenase 2 (COX2) and pituitary tumor-transforming gene 1 (PTTG1) are overexpressed in human uterine leiomyomata and are involved in the pathogenesis of uterine fibroids (UFs). We found that COX2 and PTTG1 were overexpressed in UtLM and that BBR decreased COX2 and PTTG1 expression in UtLM cells. Our data support that UtLM and UtSM are immortalized cell lines without phenotypic alterations from parental cell types and suggest that COX2 and PTTG1 are molecular targets for BBR. However, studies in these cell lines may not reveal all activities of BBR in vivo, and we therefore proceeded to test in this report the antitumor effects of BBR in an UF nude mouse xenograft model. When UF nude mice were killed at 7 weeks, tumor weight in controls was 45 ± 7 mg versus 20 ± 3 mg (P < .05) in the low-dose (5 mg/kg) and 7 ± 3 mg (P < .01) in the high-dose (10 mg/kg) BBR groups, respectively. Expression of proliferation markers, cell cycle-related genes, and UF-related genes was downregulated in tumors. No unusual behavioral changes and no signs of kidney or liver damage were observed in the animals with BBR treatment. In conclusion, our data suggests that (a) COX2 and PTTG1 are molecular targets for BBR and (b) BBR is potentially an effective and safe anti-UF agent.",
keywords = "berberine, COX2, leiomyoma, PTTG1, uterine fibroids",
author = "Chuang, {Tung Yueh} and Jie Min and Wu, {Hsiao Li} and Cristina McCrary and Layman, {Lawrence C.} and Diamond, {Michael P.} and Ricardo Azziz and Ayman Al-Hendy and Chen, {Yen Hao}",
note = "{\circledC} The Author(s) 2016.",
year = "2016",
month = "10",
day = "30",
doi = "10.1177/1933719116675055",
language = "English (US)",
volume = "24",
pages = "1005--1013",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "7",

}

TY - JOUR

T1 - Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1

AU - Chuang, Tung Yueh

AU - Min, Jie

AU - Wu, Hsiao Li

AU - McCrary, Cristina

AU - Layman, Lawrence C.

AU - Diamond, Michael P.

AU - Azziz, Ricardo

AU - Al-Hendy, Ayman

AU - Chen, Yen Hao

N1 - © The Author(s) 2016.

PY - 2016/10/30

Y1 - 2016/10/30

N2 - We previously demonstrated that berberine (BBR) inhibits cell proliferation and induces apoptosis in a human uterine leiomyoma (UtLM) cell line but does not demonstrate a significant cytotoxic effect in a normal human uterine smooth muscle (UtSM) cell line. However, the mechanisms of this inhibition are unclear. Of note, cyclooxygenase 2 (COX2) and pituitary tumor-transforming gene 1 (PTTG1) are overexpressed in human uterine leiomyomata and are involved in the pathogenesis of uterine fibroids (UFs). We found that COX2 and PTTG1 were overexpressed in UtLM and that BBR decreased COX2 and PTTG1 expression in UtLM cells. Our data support that UtLM and UtSM are immortalized cell lines without phenotypic alterations from parental cell types and suggest that COX2 and PTTG1 are molecular targets for BBR. However, studies in these cell lines may not reveal all activities of BBR in vivo, and we therefore proceeded to test in this report the antitumor effects of BBR in an UF nude mouse xenograft model. When UF nude mice were killed at 7 weeks, tumor weight in controls was 45 ± 7 mg versus 20 ± 3 mg (P < .05) in the low-dose (5 mg/kg) and 7 ± 3 mg (P < .01) in the high-dose (10 mg/kg) BBR groups, respectively. Expression of proliferation markers, cell cycle-related genes, and UF-related genes was downregulated in tumors. No unusual behavioral changes and no signs of kidney or liver damage were observed in the animals with BBR treatment. In conclusion, our data suggests that (a) COX2 and PTTG1 are molecular targets for BBR and (b) BBR is potentially an effective and safe anti-UF agent.

AB - We previously demonstrated that berberine (BBR) inhibits cell proliferation and induces apoptosis in a human uterine leiomyoma (UtLM) cell line but does not demonstrate a significant cytotoxic effect in a normal human uterine smooth muscle (UtSM) cell line. However, the mechanisms of this inhibition are unclear. Of note, cyclooxygenase 2 (COX2) and pituitary tumor-transforming gene 1 (PTTG1) are overexpressed in human uterine leiomyomata and are involved in the pathogenesis of uterine fibroids (UFs). We found that COX2 and PTTG1 were overexpressed in UtLM and that BBR decreased COX2 and PTTG1 expression in UtLM cells. Our data support that UtLM and UtSM are immortalized cell lines without phenotypic alterations from parental cell types and suggest that COX2 and PTTG1 are molecular targets for BBR. However, studies in these cell lines may not reveal all activities of BBR in vivo, and we therefore proceeded to test in this report the antitumor effects of BBR in an UF nude mouse xenograft model. When UF nude mice were killed at 7 weeks, tumor weight in controls was 45 ± 7 mg versus 20 ± 3 mg (P < .05) in the low-dose (5 mg/kg) and 7 ± 3 mg (P < .01) in the high-dose (10 mg/kg) BBR groups, respectively. Expression of proliferation markers, cell cycle-related genes, and UF-related genes was downregulated in tumors. No unusual behavioral changes and no signs of kidney or liver damage were observed in the animals with BBR treatment. In conclusion, our data suggests that (a) COX2 and PTTG1 are molecular targets for BBR and (b) BBR is potentially an effective and safe anti-UF agent.

KW - berberine

KW - COX2

KW - leiomyoma

KW - PTTG1

KW - uterine fibroids

UR - http://www.scopus.com/inward/record.url?scp=85020501810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020501810&partnerID=8YFLogxK

U2 - 10.1177/1933719116675055

DO - 10.1177/1933719116675055

M3 - Article

VL - 24

SP - 1005

EP - 1013

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 7

ER -